Results 21 to 30 of about 3,421,970 (401)

mRNA Vaccine Platform: mRNA Production and Delivery

open access: yesRussian Journal of Bioorganic Chemistry, 2023
Vaccination is the most efficient way to prevent infectious diseases. mRNA-based vaccines is a new approach to vaccine development, which have several very useful advantages over other types of vaccines. Since mRNA encodes only the target antigen there is no potential risk of infection as in the case with attenuated or inactivated pathogens.
Litvinova, V. R.   +3 more
openaire   +2 more sources

Snca and Bdnf gene expression in the VTA and raphe nuclei of midbrain in chronically victorious and defeated male mice [PDF]

open access: yes, 2010
The study aimed to analyze the mRNA levels of Snca and Bdnf genes in the ventral tegmental area (VTA) and raphe nuclei of the midbrain in male mice that had each won or defeated 20 encounters in daily agonistic interactions.
Mark R. Cookson   +4 more
core   +11 more sources

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

open access: yesNew England Journal of Medicine, 2020
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine.
L. Jackson   +32 more
semanticscholar   +1 more source

MicroRNA: a clinician’s view of the state of the problem. Part 3: MicroRNA and approaches to the treatment of cardiovascular diseases

open access: yesЕвразийский Кардиологический Журнал, 2023
Cardiovascular diseases  are one of the most common  causes of death in both developing and developed countries of the world. Despite the improvement in primary prevention, the prevalence of cardiovascular diseases has continued to grow  in recent years.
O. Iu. Mironova   +3 more
doaj   +1 more source

Myocarditis With COVID-19 mRNA Vaccines

open access: yesCirculation, 2021
Supplemental Digital Content is available in the text. Myocarditis has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) mRNA vaccinations, especially in young adult and adolescent males.
B. Bozkurt, I. Kamat, P. Hotez
semanticscholar   +1 more source

Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patients with previously untreated HER2-positive metastatic breast cancer. [PDF]

open access: yes, 2014
IntroductionThe purpose of this study was to retrospectively explore the relationship between human epidermal growth factor receptor 2 (HER2) messenger RNA (mRNA) expression and efficacy in patients receiving trastuzumab plus docetaxel (HT) or ...
Amler, Lukas C   +6 more
core   +10 more sources

Identification of potential genes associated with immune cell infiltration in atherosclerosis

open access: yesMathematical Biosciences and Engineering, 2021
Background: This study aimed to analyze the potential genes associated with immune cell infiltration in atherosclerosis (AS). Methods: Gene expression profile data (GSE57691) of human arterial tissue samples were downloaded, and differentially ...
Xiaodong Xia   +6 more
doaj   +1 more source

An agent-based model for mRNA export through the nuclear pore complex. [PDF]

open access: yes, 2014
mRNA export from the nucleus is an essential step in the expression of every protein- coding gene in eukaryotes, but many aspects of this process remain poorly understood.
Azimi, Mohammad   +3 more
core   +2 more sources

mRNA-based therapeutics: powerful and versatile tools to combat diseases

open access: yesSignal Transduction and Targeted Therapy, 2022
The therapeutic use of messenger RNA (mRNA) has fueled great hope to combat a wide range of incurable diseases. Recent rapid advances in biotechnology and molecular medicine have enabled the production of almost any functional protein/peptide in the ...
Shugang Qin   +10 more
semanticscholar   +1 more source

Dangers of mRNA vaccines

open access: yesIndustrial Psychiatry Journal, 2021
“Necessity is the mother of invention:” An adage was brought to life with the emergence of the mRNA vaccine against the backdrop of the foreboding and mercurial COVID-19 pandemic. Considering a negligible adverse-effect profile and a break-neck manufacturing speed, it shone bright as the ideal vaccine candidate.
AV Sowmya   +4 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy